Aware, Inc. 在美国、英国及国际范围内提供生物识别软件产品和解决方案。公司总部位于马萨诸塞州贝德福德。
财务指标
营业收入
2026-06-30
$325.4万
2026-03-31
$338.6万
2025-12-31
$466.3万
2025-09-30
$512.8万
营业支出
2026-06-30
$547.3万
2026-03-31
$670.2万
2025-12-31
$586.6万
2025-09-30
$592.9万
净利润
2026-06-30
-$256.5万
2026-03-31
-$345.8万
2025-12-31
-$145.5万
2025-09-30
-$105万
净利润率
2026-06-30
-78.82%
2026-03-31
-102.12%
2025-12-31
-31.2%
2025-09-30
-20.47%
每股收益
2026-06-30
$-0.12
2026-03-31
$-0.16
2025-12-31
$-0.06
2025-09-30
$-0.05
息税折旧摊销前利润
2026-06-30
-$242.4万
2026-03-31
-$331.1万
2025-12-31
-$109.6万
2025-09-30
-$90.1万
有效税率
2026-06-30
-0.03%
2026-03-31
-0.23%
2025-12-31
-17.7%
2025-09-30
-0.47%
项目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
营业收入
$325.4万
$338.6万
$466.3万
$512.8万
营业支出
$547.3万
$670.2万
$586.6万
$592.9万
净利润
-$256.5万
-$345.8万
-$145.5万
-$105万
净利润率
-78.82%
-102.12%
-31.2%
-20.47%
每股收益
$-0.12
$-0.16
$-0.06
$-0.05
息税折旧摊销前利润
-$242.4万
-$331.1万
-$109.6万
-$90.1万
有效税率
-0.03%
-0.23%
-17.7%
-0.47%
常见问题
AWRE refers to the common stock of Aware, Inc., a company that provides biometric software and services. The ticker AWRE trades on the Nasdaq stock exchange. Shares represent partial ownership in the company, giving investors a claim on its future earnings and assets. AWRE is a small-cap stock, so its price can be more sensitive to company-specific news and market sentiment than larger, more established firms. For current details about Aware's business lines or share structure, refer to the latest AWRE data displayed on this page.
The latest AWRE stock price is shown at the top of this page and updates throughout the trading day. Because market prices change constantly during market hours, the most accurate current quote is the one displayed here. For historical closing prices, intraday charts, or after-hours movement, review the price and performance sections on this page. Avoid relying on stale quotes from other sources, as AWRE is a small-cap stock and its price can move quickly on relatively low trading volume.
Recent performance for AWRE is best measured using the price charts and return figures provided on this page, which show changes over periods such as one day, one week, one month, and year to date. Because AWRE trades with relatively low liquidity, daily price swings can be larger than those of larger technology stocks, and short-term performance may reflect a handful of trades. Compare the displayed performance data with the broader Nasdaq index to see whether AWRE is outperforming or lagging the market.
Valuation for AWRE can be assessed using metrics such as price-to-sales, price-to-book, and price-to-earnings, though the usefulness of each depends on whether Aware is profitable. For a small-cap software and biometrics company, price-to-sales and enterprise value relative to revenue are often more informative than a P/E ratio when earnings are volatile or negative. Compare AWRE's multiples with those of similar biometric and software peers, and review the valuation section on this page for the latest figures. No single metric gives a complete picture.
Fractional share availability for AWRE depends on the broker. Many major U.S. brokerage platforms allow fractional investing in thousands of stocks, but each firm maintains its own list of eligible securities and may exclude smaller or less liquid names such as AWRE. Check your broker's fractional trading policies or search for AWRE in its platform to confirm eligibility. If fractional shares are unavailable, you must purchase at least one full share, and the minimum cost equals the current AWRE share price shown on this page.
AWRE carries risks tied to its small-cap status, including lower trading volume, wider bid-ask spreads, and greater price volatility than large-cap stocks. As a biometric software company, Aware faces competition, rapid technological change, reliance on government and enterprise contracts, and potential delays in customer adoption. Revenue concentration and uneven profitability can also pressure the share price. Additionally, broader market, interest-rate, and economic conditions may affect small-cap technology stocks disproportionately. Review AWRE's risk factors in its SEC filings for company-specific details.